The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: rituximab     Quarter: 2016Q3

Total Records: 1,104     Number of Pages: 56

DRUGNAME PT EventCount
RITUXIMAB Lower respiratory tract infection 10
Rituximab Lymphadenopathy 10
Rituximab Lymphopenia 10
Rituximab Micturition urgency 10
RITUXIMAB Oral mucosal eruption 10
Rituximab Osteoarthritis 10
RITUXIMAB Respiratory tract infection 10
Rituximab Urosepsis 10
Rituximab Urticaria 10
RITUXIMAB Activities of daily living impaired 9
RITUXIMAB Acute lung injury 9
RITUXIMAB Arthritis 9
Rituximab Campylobacter gastroenteritis 9
rituximab Diabetes mellitus inadequate control 9
Rituximab Dizziness 9
Rituximab Erythema 9
Rituximab Genitourinary tract infection 9
Rituximab Haemorrhoids 9
Rituximab Limb injury 9
RITUXIMAB Myelodysplastic syndrome 9

Total Records: 1,104     Number of Pages: 56